1,075
Participants
Start Date
October 3, 2022
Primary Completion Date
December 15, 2023
Study Completion Date
December 15, 2023
SUZ
Tablets for oral administration.
HB/APAP
Capsules for oral administration.
Placebo (matched to SUZ)
Placebo matched to SUZ for oral administration.
Placebo (matched to HB/APAP)
Placebo matched to HB/APAP for oral administration.
Atlanta Center for Medical Research, Atlanta
Clinical Pharmacology of Miami, Hialeah
ForCare Clinical Research, Tampa
Shoals Medical Trials Inc., Sheffield
Midwest Clinical Research Center, Dayton
Kansas Spine and Specialty Hospital, Wichita
Woodland International Research Group, Little Rock
Center for Orthopaedic Reconstruction and Excellence, Jenks
Houston Physicians Hospital, Webster
Endeavor Clinical Trials, San Antonio
Futuro Clinical Trials, McAllen
JBR Clinical Research, Salt Lake City
Arizona Research Center, Phoenix
New Hope Research Development, Tarzana
New Hope Research Development, West Covina
Pacific Research Network Inc, San Diego
Anaheim Clinical Trials, Anaheim
Trovare Clinical Research, Bakersfield
"HD Research LLC , First Surgical Hospital"
"HD Research LLC , Legent Orthopedic Hospital"
"HD Research LLC , Houston Heights Hospital"
Vertex Pharmaceuticals Incorporated
INDUSTRY